H. U. Bryant

Molecular determinants of tissue selectivity in estrogen receptor modulators.

C. D. Jones, K. Matsumoto, J. Dodge, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.

H W Cole, C. D. Jones, K. Matsumoto, 1997, Journal of medicinal chemistry.

Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate.

S. Chandrasekhar, H. Bryant, D. Magee, 1996, Bone.

Differential responses of estrogen target tissues in rats including bone to clomiphene, enclomiphene, and zuclomiphene.

C. Turner, R. Turner, M. Sato, 1998, Endocrinology.

Differential Effects of Estrogen and Raloxifene on Messenger RNA and Matrix Metalloproteinase 2 Activity in the Rat Uterus

A. Geiser, J. Dodge, S. Estrem, 2005, Biology of reproduction.

Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism

Catherine Z. Chen, Wei Zheng, G. Tawa, 2018, British journal of pharmacology.

The effects of raloxifene on tibia histomorphometry in ovariectomized rats.

R. Turner, M. Sato, H. Bryant, 1994, Endocrinology.

Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators.

H W Cole, M. Sato, L. Short, 1998, Journal of medicinal chemistry.

The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing.

H. Bryant, P. C. Francis, J. Buelke-Sam, 1998, Reproductive toxicology.